Why are Eli Lilly's 8.4 billion anti-cancer “nuclear bomb” overseas battlefield giants gathering money in the domestic radiotherapy market?

① Eli Lilly and Aktis Oncology reached a multi-target discovery cooperation agreement to develop anti-tumor radiopharmaceuticals; ② Nuclear drugs designed by Aktis Oncology can directly transport alpha particles close to cancer cells; ③ CITIC Securities pointed out that the usage rate of nuclear drugs in China is low, and there is broad scope for market expansion.

cls.cn23:35

This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan

The Structure Therapeutics (NASDAQ:GPCR) stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.What Happened: JPMorgan

Benzinga21:41

Shockwave Medical Gains After HSR Waiting Period for Sale to J&J Expires

Seeking Alpha15:46

JPM Lists Stocks With the Least Price Swings, Most Attractive Option-sale Candidates

Seeking Alpha15:45

Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units Due To The Potential For Incomplete Crimp Seals - Press Release

Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units Due To The Potential For Incomple

Benzinga15:40

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic

Roundhill Investments launched a new exchange-traded fund (ETF) Tuesday. What Happened: The Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) marks a significant milestone as the world's first GLP-1 ET

Benzinga15:33